<DOC>
	<DOC>NCT00334711</DOC>
	<brief_summary>The purpose of this study is to investigate whether patients with diabetes due to Kir6.2 mutations can be treated with sulfonylurea medication rather than insulin, and if this is the case to investigate the mechanism for sulfonylurea response.</brief_summary>
	<brief_title>Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Diabetes due to KCNJ11 (Kir6.2) mutation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Permanent Neonatal Diabetes</keyword>
	<keyword>Kir6.2</keyword>
	<keyword>KCNJ11</keyword>
	<keyword>Infancy onset diabetes</keyword>
	<keyword>Sulfonylurea</keyword>
</DOC>